Occurrence and transferability of beta-lactam resistance in Enterobacteriaceae isolated in Children's University Hospital in Bratislava
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
11830947
DOI
10.1007/bf02815624
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- beta-Lactamases genetics MeSH
- beta-Lactam Resistance genetics MeSH
- beta-Lactams pharmacology MeSH
- Ceftazidime pharmacology MeSH
- Enterobacteriaceae drug effects enzymology genetics MeSH
- Enterobacteriaceae Infections epidemiology microbiology MeSH
- Infant MeSH
- Conjugation, Genetic MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Hospitals, University * MeSH
- Infant, Newborn MeSH
- Plasmids genetics MeSH
- Child, Preschool MeSH
- Check Tag
- Infant MeSH
- Humans MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Slovakia epidemiology MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- beta-Lactamases MeSH
- beta-Lactams MeSH
- Ceftazidime MeSH
Occurrence and transferability of beta-lactam resistance in 30 multi-resistant Escherichia coli, Klebsiella spp., Enterobacter spp., Pantoea agglomerans, Citrobacter freundii and Serratia marcescens strains isolated from children between 0 and 3 years of age is presented. The strains were resistant to ampicillin (30), cefoxitin (22), cefotaxime (30), ceftriaxone (30), ceftazidime (30) and aztreonam (28), but susceptible to cefepime (30) and imipenem (26). Twenty-eight of 30 isolates possessed a transferable resistance confirmed by conjugation and isolation of 79-89-kb plasmids. The beta-lactam resistance was due to production of beta-lactamases and ceftazidime proved to be stronger beta-lactamase inductor than ceftriaxone. Twenty-five clinical isolates expressed transferable extended spectrum beta-lactamases, and chromosomally encoded AmpC beta-lactamase.
See more in PubMed
Microbiologia. 1997 Sep;13(3):315-20 PubMed
Antimicrob Agents Chemother. 1999 Jul;43(7):1657-61 PubMed
Clin Infect Dis. 1997 Jan;24 Suppl 1:S19-45 PubMed
J Antimicrob Chemother. 1997 Jul;40(1):1-3 PubMed
Antimicrob Agents Chemother. 1997 May;41(5):943-9 PubMed
J Antimicrob Chemother. 1998 Oct;42(4):419-25 PubMed
J Antimicrob Chemother. 1999 Oct;44(4):489-99 PubMed
Antimicrob Agents Chemother. 1999 Jul;43(7):1669-73 PubMed
Antimicrob Agents Chemother. 1999 Feb;43(2):393-6 PubMed
Antimicrob Agents Chemother. 1999 Aug;43(8):1924-31 PubMed
J Clin Microbiol. 1984 Oct;20(4):608-13 PubMed
Antimicrob Agents Chemother. 1997 May;41(5):1127-33 PubMed
Diagn Microbiol Infect Dis. 1998 Jun;31(2):397-404 PubMed
Antimicrob Agents Chemother. 1998 Jan;42(1):53-8 PubMed
J Nurs Care Qual. 2000 Jan;14(2):57-62 PubMed
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):5-12 PubMed
J Chemother. 1999 Apr;11(2):103-6 PubMed
Antimicrob Agents Chemother. 1997 Mar;41(3):563-9 PubMed
J Antimicrob Chemother. 1996 Jul;38(1):127-32 PubMed
Eur J Clin Microbiol Infect Dis. 1994;13 Suppl 1:S2-11 PubMed
Eur J Clin Microbiol Infect Dis. 1996 May;15(5):361-4 PubMed
APMIS. 1997 Sep;105(9):708-16 PubMed
Chemotherapy. 1997 Jan-Feb;43(1):69-76 PubMed
J Antimicrob Chemother. 1995 Jan;35(1):235-6 PubMed
Am J Med. 1997 Jul;103(1):51-9 PubMed
Int J Antimicrob Agents. 2000 Sep;16(1):31-6 PubMed
Rev Infect Dis. 1986 Jul-Aug;8 Suppl 3:S292-304 PubMed
Pediatr Infect Dis J. 1998 Mar;17(3 Suppl):S4-7; discussion S20-1 PubMed
Int J Antimicrob Agents. 1998 May;10(2):135-41 PubMed
J Clin Microbiol. 1996 Jan;34(1):76-9 PubMed
J Clin Microbiol. 1994 Oct;32(10):2481-6 PubMed
Antimicrob Agents Chemother. 2000 Feb;44(2):453-5 PubMed
Rev Infect Dis. 1988 Jul-Aug;10(4):867-78 PubMed
Occurrence of plasmid-mediated ampicillin resistance among enterobacteria from the ovine rumen
